Get Live Data

Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Sinclair Pharma Share Price
  4. Sinclair Pharma Share Regulatory News
  5. Sinclair Pharma

Pin to quick picksSinclair Pharma Regulatory News (SPH)

Sinclair Pharma Information
  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sinclair Pharma

29 Oct 2018 17:30

RNS Number : 5624F
FTSE
29 October 2018
 

 

 

 

 

Sinclair Pharma (UK): Constituent DeletionChanges in FTSE UK Index Series

29 October 2018

Subject to court sanctioning the scheme of arrangement in relation to the cash acquisition of Sinclair Pharma (UK, constituent) by Huadong Medicine Aesthetics Investment Hong Kong Ltd (non constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

05 November 2018

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2018 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSEADENADLPFFF
12345678910
Date   Source Headline
24th Sep 20182:13 pmRNSForm 8.3 - Sinclair Pharma Plc
24th Sep 20181:58 pmBUSForm 8.3 - Sinclair Pharma plc - Amendment
24th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
24th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
24th Sep 20187:00 amBUSForm 8.3 - Sinclair Pharma plc
21st Sep 20183:48 pmRNSRobert Stuart Swanson-Form 8.3 Sinclair Pharma plc
21st Sep 20183:14 pmRNSForm 8.3 - Sinclair Pharma PLC
21st Sep 20182:18 pmRNSForm 8.3 - Sinclair Pharma PLC
21st Sep 20181:58 pmBUSForm 8.3 - Sinclair Pharma plc
21st Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
21st Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
20th Sep 20183:06 pmRNSForm 8.3 - Sinclair Pharma Plc
20th Sep 20182:55 pmBUSForm 8.3 - Sinclair Pharma plc
20th Sep 20182:42 pmRNSForm 8.3 - Sinclair Pharma
20th Sep 20182:34 pmRNSForm 8.3 - Sinclair Pharma Plc
20th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
20th Sep 20188:52 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
20th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma PLC
19th Sep 20183:29 pmRNSHolding(s) in Company
19th Sep 20182:29 pmRNSForm 8.3 - [Sinclair Pharma PLC]
19th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Sep 201810:29 amRNSForm 8.3 - SINCLAIR PHARMA PLC
19th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
18th Sep 20182:55 pmRNSForm 8.3 - Sinclair Pharma Plc
18th Sep 20182:53 pmRNSForm 8.3 - Sinclair Pharma Plc
18th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Sep 20189:36 amRNSForm 8.3 - SINCLAIR PHARMA PLC
18th Sep 20188:14 amRNSHolding(s) in Company
18th Sep 20188:02 amRNSRecommended Cash Offer for Sinclair Pharma plc
18th Sep 20188:01 amRNSRecommended Cash Offer for Sinclair Pharma plc
18th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
17th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
17th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
14th Sep 201812:08 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
14th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
13th Sep 20181:49 pmRNSForm 8.3 - Sinclair Pharma plc
13th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12th Sep 201810:35 amRNSForm 8.3 - SINCLAIR PHARMA PLC
12th Sep 20189:52 amRNSForm 8.3 - Sinclair Pharma Plc
12th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma PLC
11th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Sep 20189:58 amRNSResponse to update re possible offer for Sinclair
11th Sep 20189:52 amRNSForm 8.3 - SINCLAIR PHARMA PLC
11th Sep 20189:46 amRNSUpdate re Possible Offer for Sinclair Pharma plc
10th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
7th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
6th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
5th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.